Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.860
+0.120 (6.90%)
At close: Nov 20, 2024, 4:00 PM
1.861
+0.001 (0.06%)
After-hours: Nov 20, 2024, 6:05 PM EST
Milestone Pharmaceuticals Market Cap
Milestone Pharmaceuticals has a market cap or net worth of $123.20 million as of November 21, 2024. Its market cap has increased by 0.67% in one year.
Market Cap
123.20M
Enterprise Value
100.80M
1-Year Change
0.67%
Ranking
Category
Stock Price
$1.86
Market Cap Chart
Since May 9, 2019, Milestone Pharmaceuticals's market cap has decreased from $363.46M to $123.20M, a decrease of -66.10%. That is a compound annual growth rate of -17.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 115.25M | 60.28% |
| Dec 29, 2023 | 71.91M | -57.49% |
| Dec 30, 2022 | 169.15M | -38.80% |
| Dec 31, 2021 | 276.39M | 38.33% |
| Dec 31, 2020 | 199.81M | -49.04% |
| Dec 31, 2019 | 392.14M | 7.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InflaRx | 120.12M |
| Elutia | 119.49M |
| Telomir Pharmaceuticals | 115.92M |
| TELA Bio | 115.01M |
| Rani Therapeutics Holdings | 113.94M |
| Journey Medical | 113.79M |
| Fennec Pharmaceuticals | 113.02M |
| Seres Therapeutics | 111.70M |